A. G. Beiske
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
A. G. Beiske has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
E. Svensson
Department of Adult Mental Health, Division of Mental Health, Norwegian Institute of Public Health, Oslo, Norway
2 shared publicationsB. Czujko
Department of Psychiatry, Ullevål University Hospital, Oslo
1 shared publicationE. D. Pedersen
Department of Neurology, Akershus University Hospital, Nordbyhagen
1 shared publicationH. Naess
Department of Neurology, Haukeland University Hospital, Bergen, Norway
1 shared publicationH.J. Hansen
Department of Neurology, Aarhus Hospital, Aarhus University Hospital, Aarhus, Denmark
1 shared publicationI. Elovaara
Neuroimmunology Unit, Department of Neurology, Tampere University Hospital and Medical School, University of Tampere, Tampere, Finland
1 shared publication
Latest Publications
- 1 July 2010
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 122 (s190) , 78-81
Fatigue in Parkinson’s disease: a short update
This article provides a short update on fatigue in Parkinson's disease (PD), focusing on measurements, prevalence, associated factors, pathophysiology and treatment. As long as there is no universally accepted definition of fatigue the definition used has to be stated. Different aspects of fatigue, namely physical-, mental- and chronic fatigue will be discussed. The many questionnaires used to assess fatigue measure different aspects of fatigue, making comparisons between studies difficult. Examples of uni- and multidimensional self-report questionnaires are given. In PD patients, the wide range of prevalence of fatigue (37-56%) is largely because of varying definitions of fatigue and populations tested. Without understanding the pathophysiology of subjective fatigue, the development of effective therapies is a challenge.
- 1 July 2010
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 122 (s190) , 78-81
Fatigue in Parkinson’s disease: a short update
This article provides a short update on fatigue in Parkinson's disease (PD), focusing on measurements, prevalence, associated factors, pathophysiology and treatment. As long as there is no universally accepted definition of fatigue the definition used has to be stated. Different aspects of fatigue, namely physical-, mental- and chronic fatigue will be discussed. The many questionnaires used to assess fatigue measure different aspects of fatigue, making comparisons between studies difficult. Examples of uni- and multidimensional self-report questionnaires are given. In PD patients, the wide range of prevalence of fatigue (37-56%) is largely because of varying definitions of fatigue and populations tested. Without understanding the pathophysiology of subjective fatigue, the development of effective therapies is a challenge.
- 31 October 2009
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 285, S289
PO24-TH-12 Fatigue and Parkinson's disease: prevalence and associated factors
- 31 October 2009
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 285, S289
PO24-TH-12 Fatigue and Parkinson's disease: prevalence and associated factors
- 1 April 2007
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 13 (3) , 386-392
Health-related quality of life in secondary progressive multiple sclerosis
Common disability scales in multiple sclerosis (MS) are often weighted towards physical disability. Non-motor symptoms such as depression, fatigue and pain substantially influence wellbeing in MS. Health-related quality of life (HRQoL) measures the broader impact of MS and might indicate less obvious disease burdens. We analysed HRQoL, using the Nottingham Health Profile Part I (NHP-I), among 345 secondary progressive MS (SPMS) patients participating in a randomized trial of interferon-β1a (IFN-β1a), 22 μg subcutaneously weekly, or matching placebo. The results did not reveal any beneficial effect of IFN-β1a in any outcome measure. NHP-I sub- and sum scores were compared for 217 population controls and correlated with demographic and clinical disease variables. SPMS patients had lower NHP-I sum and all subscores than the controls. Patients experiencing disease progression reported worse NHP-I sum scores. Increased fatigue, Expanded Disability Status Scale (EDSS) and Arm Index scores were independently associated with reduction in several NHP-I subscores. SPMS patients had significantly lower HRQoL than controls and physical disability (EDSS and Arm Index), disease progression and fatigue strongly influenced this. MS
- 1 April 2007
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 13 (3) , 386-392
Health-related quality of life in secondary progressive multiple sclerosis
Common disability scales in multiple sclerosis (MS) are often weighted towards physical disability. Non-motor symptoms such as depression, fatigue and pain substantially influence wellbeing in MS. Health-related quality of life (HRQoL) measures the broader impact of MS and might indicate less obvious disease burdens. We analysed HRQoL, using the Nottingham Health Profile Part I (NHP-I), among 345 secondary progressive MS (SPMS) patients participating in a randomized trial of interferon-β1a (IFN-β1a), 22 μg subcutaneously weekly, or matching placebo. The results did not reveal any beneficial effect of IFN-β1a in any outcome measure. NHP-I sub- and sum scores were compared for 217 population controls and correlated with demographic and clinical disease variables. SPMS patients had lower NHP-I sum and all subscores than the controls. Patients experiencing disease progression reported worse NHP-I sum scores. Increased fatigue, Expanded Disability Status Scale (EDSS) and Arm Index scores were independently associated with reduction in several NHP-I subscores. SPMS patients had significantly lower HRQoL than controls and physical disability (EDSS and Arm Index), disease progression and fatigue strongly influenced this. MS
- 1 July 2004
- Published by Wiley in European Journal of Neurology
- Vol. 11 (7) , 479-482
Pain and sensory complaints in multiple sclerosis
Pain is a frequent and disabling symptom among multiple sclerosis (MS) patients. The importance of this problem was investigated in a hospital based MS population.A total of 142 MS patients underwent neurological examination and a structured interview for registration of pain and sensory symptoms.One‐hundred and five patients reported sensory and/or pain symptoms. Pain was reported by 93 patients and was most frequently located in the limbs and lumbar region. The presence of pain was independent of gender, age at onset and examination, disability, disease course and duration. The most frequently reported characteristics of the symptoms were paresthesia, neuralgia and deep muscular aching. About 40% of the patients reported that the symptoms had important influence on daily activities. Only one‐third of the patients were treated for their pain.Pain is a frequent and disabling symptom, independent of demographic and clinical variables in MS patients. The low frequency of treatment for these symptoms indicates a need for improved attention to this problem.
- 1 July 2004
- Published by Wiley in European Journal of Neurology
- Vol. 11 (7) , 479-482
Pain and sensory complaints in multiple sclerosis
Pain is a frequent and disabling symptom among multiple sclerosis (MS) patients. The importance of this problem was investigated in a hospital based MS population.A total of 142 MS patients underwent neurological examination and a structured interview for registration of pain and sensory symptoms.One‐hundred and five patients reported sensory and/or pain symptoms. Pain was reported by 93 patients and was most frequently located in the limbs and lumbar region. The presence of pain was independent of gender, age at onset and examination, disability, disease course and duration. The most frequently reported characteristics of the symptoms were paresthesia, neuralgia and deep muscular aching. About 40% of the patients reported that the symptoms had important influence on daily activities. Only one‐third of the patients were treated for their pain.Pain is a frequent and disabling symptom, independent of demographic and clinical variables in MS patients. The low frequency of treatment for these symptoms indicates a need for improved attention to this problem.